Pre-IPO markets moved first.
In August, ANTHROPICUSDT briefly implied ~US$2.0T (~2× Series H; ~30× run-rate / ~10× 2028 revenue midpoint in our cut).
Mid-October marketing delays the calendar — the valuation debate stays the same: how much of the listing is already in the pre-IPO curve.
Full chart in our September MMI.